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Introduction
Ischemia-reperfusion injury (IRI) following solid organ transplan-
tation is mediated by host neutrophils that, upon extravasation, 
initiate NETosis and induce allograft damage (1, 2). Following lung 
transplantation, IRI leads to primary graft dysfunction in over 50% 
of lung recipients, which is the predominant risk factor for early mor-
tality as well as chronic rejection and thus late mortality (3–6). While 
depletion of neutrophils can ameliorate IRI, it can also compromise 
the pathogen-directed response of the host (7–11). Elucidating the 
mechanisms of neutrophil trafficking into the allograft is, therefore, 
crucial to developing clinically applicable therapies against IRI.
Blood monocytes can be classified into nonclassical and classi-
cal subtypes based on cell surface markers (12, 13). Classical mono-
cytes are characterized by a high expression of the cell-surface mole-
cule Ly6C and the presence of the chemokine receptor CCR2. They 
are the predominant monocytes found in the circulation, where they 
survey organ spaces and readily respond to inflammatory cues. Clas-
sical monocytes are generally regarded as “proinflammatory,” as 
they are readily recruited to sites of infectious and sterile inflamma-
tion, where they elaborate proinflammatory cytokines and differen-
tiate into macrophages and dendritic cells (13). Nonclassical mono-
cytes, in contrast, lack expression of CCR2, but express low levels of 
Ly6C and high levels of the fractalkine receptor CX3CR1. These cells 
patrol the microvasculature in a CX3CR1-dependent manner, and 
although less is known about the development and function of non-
classical monocytes, recent studies have implicated this monocyte 
subtype in various inflammatory processes (14–21). The precise role 
of monocytes in mediating neutrophil migration into injured tissues 
remains unclear. We recently found that donor-derived nonclassical 
monocytes are necessary for early neutrophil recruitment through 
the production of the neutrophil chemoattractant MIP-2 and that 
depletion of these cells ameliorates lung IRI (21). Interestingly, using 
intravital 2-photon imaging, we have previously observed that circu-
lating monocytes facilitate neutrophil trafficking into freshly reper-
fused lungs. Furthermore, we found that pulmonary graft function 
is significantly improved when lung-transplant recipients lack CCR2 
expression, which impairs recruitment of classical monocytes to 
lung grafts (9, 22). Since both recruitment to the tissue and extrav-
asation of neutrophils into the extravascular space are necessary for 
the initiation and propagation of lung IRI (23), it can be postulated 
that classical monocytes are perhaps essential for neutrophil extrav-
asation. Therefore, we hypothesized that nonclassical and classical 
monocytes may have complementary roles in the development of 
IRI, in which nonclassical monocytes provide the initial signals for 
leukocyte recruitment, while host-derived classical monocytes are 
essential for the extravasation of neutrophils into the injured lungs.
Ischemia-reperfusion injury, a form of sterile inflammation, is the leading risk factor for both short-term mortality following 
pulmonary transplantation and chronic lung allograft dysfunction. While it is well recognized that neutrophils are critical 
mediators of acute lung injury, processes that guide their entry into pulmonary tissue are not well understood. Here, we found 
that CCR2+ classical monocytes are necessary and sufficient for mediating extravasation of neutrophils into pulmonary tissue 
during ischemia-reperfusion injury following hilar clamping or lung transplantation. The classical monocytes were mobilized 
from the host spleen, and splenectomy attenuated the recruitment of classical monocytes as well as the entry of neutrophils 
into injured lung tissue, which was associated with improved graft function. Neutrophil extravasation was mediated by 
MyD88-dependent IL-1β production by graft-infiltrating classical monocytes, which downregulated the expression of the tight 
junction–associated protein ZO-2 in pulmonary vascular endothelial cells. Thus, we have uncovered a crucial role for classical 
monocytes, mobilized from the spleen, in mediating neutrophil extravasation, with potential implications for targeting of 
recipient classical monocytes to ameliorate pulmonary ischemia-reperfusion injury in the clinic.
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IL-1β–mediated downregulation of ZO-2 was sufficient to increase 
endothelial permeability. Thus, our work uncovers what we 
believe to be a previously unrecognized mechanism by which clas-
sical monocytes mobilized from the spleen promote extravasation 
of recruited neutrophils into the lung following IRI.
Results
Classical monocytes are necessary for neutrophil extravasation fol-
lowing lung IRI. We and others have demonstrated that host neu-
trophils are critical mediators of lung IRI (2, 7–11, 25). Using our 
previously described technique of multicolor flow cytometry 
(26–29), we determined the changes in myeloid cell populations in 
the lung following IRI that was mediated by transient clamping of 
the pulmonary hilum. We observed that classical monocytes were 
recruited and host neutrophils extravasated into the lung while the 
number of nonclassical monocytes remained unchanged after IRI 
In both human lung allografts and murine models, we found 
that IRI was associated with the recruitment of classical mono-
cytes as well as neutrophils into the injured lungs. The classical 
monocytes were mobilized from the host spleen and were neces-
sary for neutrophil extravasation, since pharmacological depletion 
of CCR2+ classical monocytes as well as splenectomy abrogated 
neutrophil extravasation, while heterotopic spleen transplanta-
tion following initial splenectomy rescued the injury. To achieve 
clinical relevance, we validated these findings in an orthotopic 
vascularized murine lung-transplant model (24). We found that 
host splenectomy ameliorated IRI, while reconstitution with 
spleen- derived classical monocytes restored IRI. Neutrophil 
extravasation was mediated by MyD88-dependent IL-1β produc-
tion by classical monocytes, which resulted in downregulation of 
ZO-2, a cytoplasmic protein that interacts with transmembrane 
tight junctional proteins, in pulmonary vascular endothelial cells. 
Figure 1. Classical monocytes recruited to the lung after IRI mediate neutrophil extravasation. WT mice underwent IRI using hilar clamping, and the 
myeloid cell populations were analyzed by flow cytometry. (A) Representative flow cytometry plots (left) and quantification (right) of extravasated neutro-
phils and recruited classical monocytes (CM) in resting state or that of hilar clamp–mediated IRI are demonstrated. Neutrophils and classical monocytes 
were gated on live CD45+Ly6G+CD11b+SSChi and live CD45+Ly6G–NK1.1–SiglecF–CD11b+CD64–Ly6Chi cells, respectively. (B) Correlation between recruitment of 
classical monocytes following reperfusion of human lung allografts and increase in neutrophils in the BALF. The ratio of classical monocytes normalized 
by alveolar macrophages was correlated with an increase in bronchoalveolar neutrophils before and 15 minutes following reperfusion. Pearson’s correlation 
coefficient (r) was significant. (C) The percentage of extravasated neutrophils was determined after hilar clamp–mediated IRI in mice that were system-
ically depleted of monocytes 24 hours prior to IRI using Clo-lip (left), DT (CD11b-DTR mouse; middle), or anti-CCR2 antibody treatment (right). Data are 
expressed as median with interquartile range. n = 5–13 per group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, Mann-Whitney U test (A and C).
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in depletion of both classical and nonclassical monocytes in WT 
mice and there exists a possibility that administration of DT could 
also deplete neutrophils in CD11b-DTR mice, we next treated WT 
hosts with anti-CCR2 antibodies to selectively deplete classical 
monocytes (Supplemental Figure 2D and Supplemental Figure 4, 
A and B), as previously described (21). Anti-CCR2 antibody treat-
ment significantly reduced neutrophil extravasation, indicating 
that classical monocytes may mediate this process (Figure 1C).
The spleen is necessary for the recruitment of classical monocytes 
and neutrophil extravasation into the injured lung. Both bone mar-
row and spleen are sites where monocytes can be recruited from 
in models of lung inflammation (30). We first set out to analyze 
classical monocytes in different compartments following lung IRI. 
While the injured lungs showed an increase in classical monocytes 
(Figure 2A), levels of classical monocytes were decreased in the 
host spleen (Figure 2B), but remained constant in the bone mar-
row before and after injury (Figure 2C). Administration of anti-
CCR2 antibodies resulted in a significant reduction of classical 
monocytes in both spleen and bone marrow at baseline (Figure 2, 
(Figure 1A, Supplemental Figure 1, and Supplemental Figure 2A; 
supplemental material available online with this article; https://
doi.org/10.1172/JCI98436DS1). We also observed an increase 
in neutrophils and classical, but not nonclassical, monocytes in 
human lung allografts following reperfusion (Supplemental Fig-
ure 3). The increase in classical monocytes in human lung grafts 
correlated with an accumulation of neutrophils in the bronchoal-
veolar lavage fluid (BALF) (Figure 1B).
In order to determine whether classical monocytes were 
responsible for neutrophil extravasation, we first depleted all cir-
culating monocytes by pretreating the host with clodronate lipo-
somes (Clo-lip), a technique we have previously demonstrated 
as causing monocytopenia for at least 72 hours (Supplemental 
Figure 2B and Supplemental Figure 4) (16). This led to a signifi-
cant decrease in neutrophil extravasation following lung IRI (Fig-
ure 1C). Similarly, we found a significant reduction in neutrophil 
extravasation in CD11b-DTR mice after monocytes were depleted 
using diphtheria toxin (DT) (Figure 1C, Supplemental Figure 2C, 
Supplemental Figure 4, A and B). Since Clo-lip treatment results 
Figure 2. Classical monocytes mediating neutrophil extravasation in lungs subjected to IRI through hilar clamping are mobilized from the spleen. 
Numbers of classical monocytes in the (A) lung, (B) spleen, and (C) bone marrow before and 2 hours after hilar clamp–mediated lung IRI. Numbers of 
classical monocytes in the lung and spleen are shown after treatment with isotype control or anti-CCR2 antibody. (D) Numbers of classical monocytes in 
bone marrow of resting mice after treatment with isotype control or anti-CCR2 antibody. Data are expressed as median with interquartile range. n = 5 per 
group. *P < 0.05, Mann-Whitney U test. (E) Recruitment of classical monocytes to injured lung and (F) percentage of extravasated neutrophils in injured 
lung after hilar clamp–mediated IRI in the presence or absence of a spleen. Congenic spleen transplants were performed into hosts that had undergone 
native splenectomies. Splenectomy of the transplanted spleen (resplenectomy) rendered these mice asplenic. txp, transplant. For E, 1 statistical outlier 
in the spleen transplant and 1 statistical outlier in resplenectomy group were excluded from the analysis. For F, 1 statistical outlier was excluded in the 
splenectomy group. Data are expressed as mean ± SEM. n = 6–8 per group. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001, 1-way ANOVA with post 
hoc Holm-Šídák test (A–C, E, F).
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monocytes (Figure 2, E and F, and Supplemental Figure 2E). Sple-
nectomy did not alter the number of nonclassical monocytes in 
injured lungs (Supplemental Figure 2E). In order to further explore 
this hypothesis, we performed heterotopic congenic spleen trans-
plants (CD45.1 donor into CD45.2 recipient) after native splenec-
tomy, as previously described (31). We found that the donor spleen 
was repopulated by host-derived myeloid cells and, at 1 week, 
greater than 95% of classical monocytes were of recipient origin 
B and D). After reperfusion, treatment with anti-CCR2 antibody 
resulted in a significant reduction of classical monocytes in lungs 
and spleen (Figure 2, A and B). To determine whether classical 
monocytes can be recruited directly from the bone marrow, we 
performed a splenectomy, which resulted in a significant reduc-
tion in the recruitment of classical monocytes to the injured lungs 
along with a decrease in neutrophil extravasation, suggesting that 
the spleen serves as a reservoir for the inflammatory classical 
Figure 3. Classical monocytes are mobilized from the recipient’s spleen to lung grafts after transplantation. (A) Representative contour plots and 
histograms depict recipient (CD45.2+) CD11b+Ly6chiCCR2+ monocytes in pulmonary grafts and peripheral blood 2 hours after transplantation of B6 CD45.1+ 
lungs into control or splenectomized congenic B6 CD45.2+ mice. (B) Graphic presentation of monocytes as percentages of recipient CD45.2+ hematopoietic 
cells and absolute numbers in lung grafts and peripheral blood. Data are expressed as median with interquartile range. n = 4 per group. *P < 0.05, unpaired 
t test. (C) A CCR2-specific PET radiotracer (64Cu-DOTA-ECL1i) was injected into control (left) or splenectomized (right) B6 recipients of syngeneic lung grafts 
2 hours after transplantation and imaged by 0- to 60-minute dynamic PET/CT scanning after intravenous injection. L, liver; K, kidney; B, bladder. Circle 
shows lung graft. (D) Graphic presentation of 64Cu-DOTA-ECL1i uptake in native right lungs and pulmonary grafts 2 hours after transplantation into control 
or splenectomized syngeneic B6 recipients. Data are expressed as mean ± SEM. n = 4 per group. *P < 0.05; **P < 0.01; ****P < 0.0001, 1-way ANOVA with 
post hoc Holm-Šídák test. (E) Depletion of nonclassical monocytes in B6 donor lungs through Clo-lip or genetic deletion of NR4A1 led to a reduction in the 
serum MCP-1 levels of the BALB/c recipient 2 hours after reperfusion compared with control PBS-liposome treatment mice. (F) Recruitment of BALB/c 
recipient classical monocytes into the B6 allograft was significantly reduced 2 hours after reperfusion when donor lungs were treated with Clo-lip to 
deplete donor nonclassical monocytes or when NR4A1–/– donor lungs were used. Reconstitution of B6 NR4A1–/– lungs with WT B6 nonclassical monocytes 
prior to transplantation restored the levels of classical monocytes recruited to the donor allograft following reperfusion. Data are expressed as mean ± 
SEM. n = 5–8 per group. ****P < 0.001, 1-way ANOVA with post hoc Holm-Šídák test (E and F).
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peripheral blood and lung grafts when compared between sple-
nectomized and nonsplenectomized recipients after reperfusion 
(Figure 3, A and B). Using PET/CT with our recently described 
CCR2-specific imaging probe, we observed that, after removal of 
the recipient spleen, the signal in the lung graft was significant-
ly diminished at 2 hours after transplantation, which was similar 
to our previous observations in CCR2-deficient lung-transplant 
recipients (Figure 3, C and D) (22). Moreover, there was an overall 
decrease in PET signal in the periphery of splenectomized hosts. 
Thus, similarly to what we found in our observations in the hilar 
clamp model, the spleen is an important reservoir for inflamma-
tory classical monocytes that infiltrate transplanted lungs imme-
diately after reperfusion. Given that we have previously shown 
that donor nonclassical monocytes mediate the recruitment of 
recipient neutrophils into pulmonary grafts, we next set out to 
determine whether nonclassical monocytes played a role in the 
recruitment of classical monocytes into the transplanted lung 
(21). At baseline, classical monocytes were more abundant in 
both bone marrow and spleen compared with nonclassical mono-
cytes (Supplemental Figure 7). However, while more classical 
monocytes were present in the bone marrow compared with the 
spleen, we observed more nonclassical monocytes in the spleen 
(Supplemental Figure 5). Mice that underwent a native splenec-
tomy and received heterotopic spleen transplants demonstrated 
preserved recipient-derived classical monocyte infiltration into 
the lung as well as neutrophil extravasation following pulmonary 
IRI. Moreover, removal of the transplanted spleen prior to lung 
IRI abrogated classical monocyte recruitment and neutrophil 
extravasation, which was similar to our observations in WT mice 
after splenectomy (Figure 2, E and F). This further confirmed the 
importance of the spleen as a source of inflammatory classical 
monocytes that are recruited to injured lungs. Notably, splenecto-
my did not affect neutrophil extravasation in other models of lung 
injury, including administration of intratracheal LPS or acid aspi-
ration (Supplemental Figure 6).
Next, to achieve clinical relevance, we used a murine vascu-
larized lung-transplant model to investigate the role of the spleen 
as a reservoir for inflammatory classical monocytes. Unlike the 
hilar clamp model, in which the lungs are subjected to warm isch-
emia, the lung-transplant model mimics the clinical situation in 
which lungs undergo a period of cold ischemia prior to reperfusion 
(24). We splenectomized recipient C57BL/6 (B6) CD45.2 mice 
prior to transplantation of congenic B6 CD45.1 lungs. The abun-
dance of classical monocytes was significantly decreased in the 
Figure 4. Spleen-derived classical monocytes promote neutrophil extravasation into lung grafts after transplantation. (A) Arterial blood oxygenation 
was assessed, and absolute numbers of neutrophils were determined in (B) lung grafts 24 hours after transplantation of B6 CD45.1+ lungs into control or 
splenectomized congenic B6 CD45.2+ recipients. (C) Contour plots depicting gating strategy to identify intravascular vs. extravascular recipient neutrophils 
(CD45.2+CD11b+Gr-1+) and quantification of the percentage of graft-infiltrating neutrophils 24 hours after transplantation of B6 CD45.1+ lungs into control or 
splenectomized congenic B6 CD45.2+ hosts. Debris, dead cells, and doublets have been excluded from analysis based on forward scatter/side scatter (FSC/
SSC) and FSC–pulse area [FSC-A]/FSC–pulse width [FSC-W] characteristics. (D) Absolute numbers of neutrophils were determined in the BALF 24 hours 
after transplantation of B6 CD45.1+ lungs into control or splenectomized congenic B6 CD45.2+ recipients. Data for A–D are expressed as median with inter-
quartile range. n = 4 per group for arterial blood gas measurement; n = 7 per group for enumeration of neutrophils in lung grafts and BALF. *P < 0.05; **P < 
0.01, Mann-Whitney U test. (E) Expression levels of Il1b, Tnfa, Cxcl1, Cxcl2, and Cxcl5 in B6 CD45.1+ lung grafts 24 hours after transplantation into control or 
splenectomized congenic B6 CD45.2+ hosts, assessed by quantitative real-time PCR. Results were normalized to Rn18s. Data are expressed as median with 
interquartile range. n = 5 per group. *P < 0.05; **P < 0.01, Mann-Whitney U test.
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Figure 5. IL-1β production by graft-infiltrating monocytes is essential for neutrophil extravasation after lung transplantation. (A) Recipient mono-
cytes (CD45.2+CD11b+Ly6Chi) were isolated from the bone marrow or lung grafts in resting mice or 2 hours after transplantation of B6 CD45.1+ lungs into 
B6 CD45.2+ recipients, and their expression levels of Il1b, Tnfa, Cxcl1, Cxcl2, and Cxcl5 were analyzed by quantitative PCR. n = 4 each compartment with 1 
statistical outlier for Cxcl1 and 1 statistical outlier for Cxcl5 in the lung excluded from analysis. *P < 0.05, Mann-Whitney U test. (B) Expression levels of 
IL1B in human donor grafts at conclusion of cold ischemia and 2 hours after reperfusion, assessed by quantitative PCR. n = 5. **P < 0.01, paired t test. (C) 
Arterial blood oxygenation was assessed and absolute numbers of recipient (D) monocytes and (E) neutrophils were determined in lung grafts 24 hours 
after transplantation of B6 CD45.1+ lungs into splenectomized congenic B6 CD45.2+ recipients that received either B6 WT or B6 IL-1β–deficient monocytes. 
Data are expressed as median with interquartile range. n = 6 per group. **P < 0.01, Mann-Whitney U test. (F) Representative contour plots of extravascular 
vs. intravascular neutrophils and quantification of the percentage of graft-infiltrating neutrophils in lung grafts and (G) number of neutrophils in BALF 24 
hours after transplantation of B6 CD45.1+ lungs into splenectomized B6 CD45.2+ recipients that received B6 WT or B6 IL-1β–deficient monocytes. Data are 
expressed as median with interquartile range. n = 6 per group. *P < 0.05; **P < 0.01, Mann-Whitney U test. (H) Representative intravital 2-photon micros-
copy of B6 WT or B6 IL-1R–KO lung grafts 2 hours after transplantation into syngeneic B6 LysM-GFP mice and quantification of neutrophil extravasation. 
Qdot 655 labeled the vessels red. Recipient neutrophils are green. Scale bar: 50 μm. Data are expressed as median with interquartile range. n = 4 per group. 
*P < 0.05, Mann-Whitney U test.
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compared with the bone marrow (Supplemental Figure 7). We 
observed that serum levels of the CCR2 ligand MCP-1 were sig-
nificantly reduced after lung transplantation when grafts were 
devoid of nonclassical monocytes, which was achieved by pre-
treating lung donors with Clo-lip injection or by using donors that 
were deficient in NR4A1, a transcription factor that is necessary 
for the development of nonclassical monocytes (Figure 3E) (17). 
Recruitment of classical monocytes was significantly reduced 
after transplantation of donor lungs that lack nonclassical mono-
cytes (Figure 3F). Importantly, reconstitution of NR4A1-deficient 
grafts with WT nonclassical monocytes restored the recruitment 
of classical monocytes to the transplanted lung. Thus, in addition 
to their previously reported role in mediating neutrophil recruit-
ment, donor nonclassical monocytes promote the recruitment of 
classical monocytes from the recipient’s spleen.
Having shown that spleen-derived classical monocytes infil-
trate lung grafts shortly after reperfusion, we next set out to deter-
mine whether IRI following lung transplantation is affected by the 
removal of the recipient’s spleen. Compared with what occurred 
in control recipients, graft function was significantly better in 
splenectomized hosts (Figure 4A). Since neutrophils play a crucial 
role in lung IRI, we next compared neutrophil graft infiltration 
in nonsplenectomized and splenectomized lung recipients. Host 
splenectomy prior to lung transplantation resulted in an overall 
reduction of recipient neutrophils in the graft tissue (Figure 4B). 
Splenectomy resulted in a significant decrease in the percentage 
of neutrophils that exited the vascular compartment (Figure 4C) 
and a lower abundance of neutrophils in the airways (Figure 4D), 
indicating a lower degree of tissue entry and thus supporting the 
notion that classical monocytes are necessary for the extrava-
sation of host neutrophils following lung IRI. Graft function and 
neutrophil extravasation in recipients that underwent a sham lap-
arotomy prior to lung transplantation were comparable to that in 
nonsplenectomized hosts (Supplemental Figure 8, A and B). Fur-
thermore, we observed significantly lower levels of the proinflam-
matory cytokines Il1b and Tnfa (Figure 4E) as well as the neutro-
phil chemokines Cxcl1 and Cxcl2, but not Cxcl5 transcripts in lung 
grafts after transplantation into splenectomized hosts (Figure 4E).
Monocyte-derived IL-1β plays a critical role in neutrophil 
extravasation. In order to elucidate how monocytes regulate 
neutrophil graft infiltration and their extravasation, we sort-
ed recipient-derived graft-infiltrating classical monocytes and 
analyzed their gene expression by quantitative reverse-tran-
scription PCR (RT-PCR). Compared with classical monocytes 
that were concurrently isolated from the bone marrow of these 
lung-transplant recipients, Il1b expression levels were several 
thousandfold higher in graft-infiltrating classical monocytes 
shortly after reperfusion (Figure 5A). Expression levels of Tnfa 
and Cxcl2 were also increased in graft-infiltrating monocytes, 
although they were less pronounced than Il1b (Figure 5A). At 
baseline, we also observed higher expression of Il1b, Tnfa, 
and Cxcl2 in lung compared with bone marrow monocytes, 
although the differences were less pronounced than after IRI 
(Supplemental Figure 9). Fractalkine/Cx3cl1 expression could 
not be detected in monocytes in either compartment (data not 
shown). Expression levels of IL1B, but not TNFA, were found to 
be significantly elevated in human lung grafts after reperfusion 
(Figure 5B and Supplemental Figure 10). Based on the marked-
ly elevated levels of IL-1β in graft-infiltrating classical mono-
cytes, we next evaluated whether expression of this cytokine in 
monocytes regulated neutrophil extravasation into lung grafts 
during IRI. To this end, we injected splenic classical mono-
cytes isolated from either WT or IL-1β–deficient B6 CD45.2 
mice into splenectomized B6 CD45.2 recipients 1 hour prior to 
transplantation of congenic B6 CD45.1 lungs. Graft function 
was significantly better after injection of IL-1β–deficient com-
pared with WT classical monocytes (Figure 5C). In fact, graft 
function after adoptive transfer of WT classical monocytes into 
splenectomized recipients was comparable to that observed 
after lung transplantation into nonsplenectomized hosts, 
while graft function after adoptive transfer of IL-1β–deficient 
classical monocytes into splenectomized recipients was not 
significantly different from that in splenectomized recipients 
that did not receive monocyte injections (Figure 4A). While 
the absolute numbers of classical monocytes and neutrophils 
in lung grafts did not differ between the 2 experimental adop-
tive transfer groups (Figure 5, D and E), a higher percentage 
of graft-infiltrating neutrophils had left the vascular compart-
ment (Figure 5F) and a greater number of neutrophils had 
entered the airways (Figure 5G) after adoptive transfer of WT 
compared with IL-1β–deficient classical monocytes. To confirm 
that IL-1β signaling regulates neutrophil trafficking in freshly 
reperfused lung grafts, we transplanted lungs that lack expres-
sion of the IL-1 receptor (IL-1R) into syngeneic LysM-GFP 
neutrophil reporter mice and imaged the grafts by intravital 
2-photon microscopy 2 hours after reperfusion. Corroborating 
our flow cytometry data, we observed that, compared with WT 
grafts, neutrophils failed to extravasate efficiently in IL-1R–
deficient lungs (Figure 5H) (Supplemental Videos 1 and 2). We 
then compared IL-1β expression in bone marrow and splenic 
classical monocytes in resting mice and after lung transplanta-
tion. Under both conditions, IL-1β expression was significantly 
increased in splenic monocytes, with a more pronounced dif-
ference after lung transplantation (Supplemental Figure 11A). 
Of note, as opposed to reconstitution with splenic monocytes, 
injection of bone marrow monocytes into splenectomized hosts 
did not restore neutrophil extravasation into pulmonary grafts 
or result in an impairment in oxygen exchange (Supplemental 
Figure 11, B and C).
MyD88 signaling in graft-infiltrating classical monocytes is neces-
sary for IL-1β production and neutrophil extravasation. We and others 
have shown that endogenous substances, which are released at the 
time of organ implantation, can activate innate immune receptors 
and trigger the release of proinflammatory cytokines, such as IL-1β 
(32). Many such endogenous triggers of inflammation, referred to 
as damage-associated molecular patterns, signal via MyD88, an 
adaptor protein downstream of all TLRs except TLR3 and down-
stream of IL-1 and IL-18 receptors. We next examined requirements 
for IL-1β production in monocytes after stimulation with lysates 
generated from B6 lungs. Expression levels of IL-1β were signifi-
cantly decreased when monocytes lacked MyD88 (Figure 6A). To 
assess the role of MyD88 signaling in graft-infiltrating monocytes in 
vivo, we transferred splenic classical monocytes from either WT or 
MyD88-deficient B6 CD45.2 mice into splenectomized B6 CD45.2 
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7C). Of note, blocking IL-1R signaling attenuated the downregula-
tion of ZO-2 (Figure 7D). We next set out to examine how expression 
of IL-1β in graft-infiltrating monocytes regulates these processes 
in vivo. Immunofluorescent staining revealed that the expression 
of ZO-2 was significantly reduced in CD31+ endothelial cells of B6 
lung grafts that were transplanted into splenectomized syngeneic 
recipients receiving WT compared with IL-1β–deficient monocytes 
(Figure 7E). We also observed significant downregulation of ZO-2 in 
human pulmonary grafts following reperfusion (Figure 7F). To eluci-
date whether downregulation of ZO-2 was sufficient to affect pulmo-
nary endothelial barrier function, an siRNA was used to knock down 
ZO-2 expression in MLVECs. The knockdown efficiency of the ZO-2 
siRNA was confirmed by Western blotting (Figure 8, A and B) and 
immunofluorescent staining of endothelial cell cultures 48 hours 
after the transfection (Figure 8C). ZO-2 knockdown resulted in 
enhanced endothelial permeability, as measured by the FITC-dex-
tran assay (Figure 8D) and neutrophil transmigration (Figure 8E).
Discussion
Lung IRI remains the predominant cause of early allograft failure 
(5, 6, 23, 33, 34). Additionally, it remains the greatest risk factor for 
the development of chronic lung allograft rejection. Hence, ame-
liorating lung IRI has the potential for substantially improving pul-
monary transplant outcomes, which still remain dismal compared 
with outcomes for transplants with other solid organs. Host neu-
trophils are now known to play a central role in the development 
hosts 1 hour prior to transplantation of congenic B6 CD45.1 pulmo-
nary grafts. Similarly to our observations with monocytes that lack 
IL-1β, oxygenation was significantly improved after injection of 
MyD88-deficient when compared with WT monocytes (Figure 6B). 
The monocyte and neutrophil numbers that had accumulated in 
the pulmonary grafts were comparable between the 2 experimental 
groups (Figure 6, C and D); however, a lower percentage of neutro-
phils extravasated and accumulated in the airways when monocytes 
lacked expression of MyD88 (Figure 6, E and F).
IL-1β produced by classical monocytes modulates endothelial tight 
junctions through downregulation of ZO-2. Having shown that neu-
trophils accumulated in lung grafts, but were unable to exit the 
vasculature efficiently when graft-infiltrating classical monocytes 
lacked expression of IL-1β or when IL-1β signaling in the graft was 
disrupted, we next wanted to determine how endothelial permea-
bility was regulated by IL-1β. We observed that exposure of primary 
mouse lung microvascular endothelial cells (MLVECs), grown on 
Transwell membranes, to IL-1β resulted in a significant increase in 
their permeability (Figure 7A). This increase in permeability was 
blunted by pretreating the cultures with an IL-1R–blocking antibody 
(Figure 7B). To examine downstream mechanisms through which 
IL-1β disrupts the pulmonary vascular endothelial barrier, we next 
focused on tight junction proteins. Immunofluorescent staining and 
Western blotting demonstrated that treatment with IL-1β resulted in 
a dose-dependent downregulation of ZO-2, a cytoplasmic protein 
that interacts with transmembrane tight junctional proteins (Figure 
Figure 6. MyD88 expression by graft-infiltrating monocytes is essential for neutrophil extravasation after lung transplantation. (A) Expression levels 
of IL-1β were assessed by quantitative real-time PCR in bone marrow–derived B6 WT or MyD88-deficient monocytes after treatment with B6 lung lysates. 
Data are expressed as mean ± SEM of 3 biological replicates. **P < 0.01, unpaired t test. (B) Arterial blood oxygenation was assessed and absolute 
numbers of recipient (C) monocytes and (D) neutrophils were determined in lung grafts 24 hours after transplantation of B6 CD45.1+ lungs into splenecto-
mized congenic B6 CD45.2+ recipients that received either B6 WT or B6 MyD88-deficient monocytes. (E) Representative contour plots of extravascular vs. 
intravascular neutrophils and quantification of the percentages of graft-infiltrated neutrophils in lung grafts as well as (F) number of neutrophils in BALF 
24 hours after transplantation of B6 CD45.1+ lungs into splenectomized congenic B6 CD45.2+ recipients that received either B6 WT or B6 MyD88-deficient 
monocytes. Data are expressed as median with interquartile range. n = 5 per group. *P < 0.05; **P < 0.01, Mann-Whitey U test (B–F).
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Many studies have demonstrated that CCR2 plays an import-
ant role in mediating the egress of inflammatory monocytes 
from the bone marrow (36). To this end, our group has previ-
ously demonstrated that CCR2 is critical for the mobilization 
of monocytes from the bone marrow into the bloodstream after 
pulmonary transplantation and for the accumulation of CD11c+ 
cells within lung allografts, which enhances alloreactivity (37). 
While most studies implicating the bone marrow as the source 
of monocytes examined accumulation of monocyte-derived 
cells at target sites several days after the inflammatory insult, 
recent seminal work using models of myocardial ischemia has 
revealed that the spleen represents the dominant reservoir for 
monocytes during early stages of inflammation (31). Our find-
ings extend these observations, as we demonstrate by both flow 
of pulmonary IRI (7–11). Neutrophil trafficking into the injured 
tissue involves the recruitment of neutrophils to the lung vascu-
lature, followed by extravasation into the interstitial and alveolar 
space (35). In our recent report, we found that donor nonclassical 
monocytes provide initial cues for the recruitment of host neutro-
phils after lung transplantation (21). Here, we demonstrate that 
extravasation of neutrophils is mediated by host-derived classical 
monocytes mobilized from the spleen to injured lungs following 
reperfusion (Figure 9). These classical monocytes produce IL-1β 
in MyD88-dependent fashion, which plays a critical and nonre-
dundant role in promoting neutrophil extravasation into the lung 
tissue by acting on the IL-1R on the pulmonary vasculature. IL-1β 
mediates downregulation of ZO-2 in pulmonary endothelial cells, 
which we show is sufficient to disrupt the endothelial barrier.
Figure 7. IL-1β mediates downregulation of 
ZO-2 in vascular endothelial cells and increases 
endothelial permeability. Permeability was 
assessed in MLVEC cultures treated with (A) 
IL-1β at indicated concentrations and (B) after 
adding IL-1R–neutralizing (2.5 μg/ml) or control 
antibody for 24 hours. For A, a representative 
experiment of 3 biological replicates is shown. 
Data represent mean ± SD of 3 technical repli-
cates. For B, data are presented as mean ± SD 
of 4 biological replicates. One statistical outlier 
was excluded in the group receiving IL-1β treat-
ment only. **P < 0.01; ***P < 0.001; ****P < 
0.001, 1-way ANOVA with post hoc Holm-Šídák 
test (A and B). RFU, relative fluorescence unit. 
(C) MLVECs were treated with IL-1β (0, 0.5, and 
1 ng/ml) for 24 hours, fixed, and stained with 
ZO-2. Nuclei were counterstained with DAPI. 
Images are representative of 3 independent 
experiments. (D) MLVECs were treated with 
IL-1R–neutralizing or control antibody for 30 
minutes prior to the addition of IL-1β (1 ng/ml). 
Cell lysates were analyzed for ZO-2 by Western 
blotting. The same blot was reprobed for GAP-
DH. Blots are representative of 3 independent 
experiments. (E) Frozen tissues of B6 CD45.1+ 
lung grafts, collected 24 hours after transplanta-
tion into splenectomized B6 CD45.2+ hosts that 
received B6 WT or B6 IL-1β–deficient monocytes 
and (F) human donor grafts at the conclusion of 
cold ischemia and 2 hours after reperfusion were 
stained with antibodies for ZO-2 (red) and CD31 
(green). Nuclei were counterstained with DAPI. 
Arrowhead indicates colocalization of CD31 and 
ZO-2. Scale bar: 20 μm. Images were taken with 
a ×40 objective lens. The relative mean fluo-
rescence intensity (MFI) of ZO-2 staining was 
quantified and is represented graphically for E 
and F. For E, data are expressed as median with 
interquartile range. n = 5 per group. *P < 0.05, 
Mann-Whitney U test. For F, n = 8 patients per 
group. *P < 0.05, paired t test.
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For many years, it had been the prevailing dogma that neutro-
phils were the first innate cells to enter lung tissue during infec-
tions and sterile inflammation. However, the development of 
approaches to imaging dynamic leukocyte behavior in live lungs 
allowed us to show that monocyte extravasation temporally pre-
cedes and is spatially associated with neutrophil extravasation (9). 
When we depleted recipient monocytes with intravenous Clo-lip, 
graft-infiltrating neutrophils adhered to the vessel wall, but their 
extravasation was impaired at the transendothelial migration step. 
Disruption of the tight junctions between endothelial cells is a key 
event that precedes the paracellular passage of leukocytes. Endo-
thelial tight junction integrity is maintained through the interplay 
of protein complexes. Transmembrane tight junctional proteins, 
such as claudins, occludins, and junctional adhesion molecules, 
are anchored to the actin cytoskeleton through cytosolic scaffold 
proteins such as ZO-1 and ZO-2. Here, we show that monocyt-
ic production of IL-1β plays a critical and nonredundant role in 
increasing endothelial permeability in reperfused lungs. While we 
cannot exclude the possibility that IL-1β directly alters the expres-
sion of other proteins that maintain the functional integrity of the 
endothelial barrier, we show that downregulation of ZO-2 is suf-
ficient to enhance endothelial permeability. It is surprising that 
other inflammatory cytokines cannot compensate for IL-1β. For 
example, we have shown that graft-infiltrating monocytes express 
high levels of TNF-α, a cytokine that has been demonstrated to 
increase the permeability of various endothelial and epithelial 
cell barriers (40, 41). Differences may exist in how tight junctional 
cytometry and PET scanning that CCR2+ monocytes are reduced 
in the periphery and in the pulmonary graft when we remove 
the recipient’s spleen prior to lung IRI. We found that hetero-
topic spleen grafts were rapidly repopulated by the host classi-
cal monocytes, which were then recruited to the injured lung. 
We further show that spleen monocytes express higher levels of 
IL-1β at baseline and after transplantation. Hence, it is likely that 
the spleen serves as a reservoir for bone marrow–derived clas-
sical monocytes, where they receive additional maturation sig-
nals that enable them to mediate neutrophil extravasation after 
their rapid release in response to lung injury. We have previously 
demonstrated that CCR2-deficient lung recipients are protect-
ed from transplant-mediated IRI and that neutrophils are the 
key mediators of IRI after lung transplantation (22, 38). Taken 
together, our findings support the notion that splenectomized 
lung recipients are protected from IRI through an impairment 
of monocyte-mediated neutrophil extravasation into the graft. 
Interestingly, we show that — in contrast with our findings in 
pulmonary IRI — removal of the spleen does not affect the entry 
of neutrophils into the lung when injury is triggered through the 
administration of intratracheal LPS or acid aspiration. We spec-
ulate that alveolar macrophages play a dominant role in orches-
trating the inflammatory response and neutrophil extravasation 
when lung injury is triggered through stimuli in the airways. To 
this end, intratracheal administration of LPS has been shown to 
induce the death of alveolar macrophages, which results in their 
release of pro–IL-1α and vascular leakage (39).
Figure 8. Knockdown of ZO-2 increases endothelial permeability. (A and B) Representative Western blot and semiquantitative analysis as well as (C) immu-
nostaining of ZO-2 in MLVECs that were transfected with control siRNA or siRNA targeting ZO-2 for 48 hours. Scale bars: 20 μm. Blots and immunostaining 
are representative of 3 independent experiments each. Data are expressed as mean ± SD. n = 6 per group. ****P < 0.0001, 1-way ANOVA with post hoc Holm-
Šídák test. (D) Endothelial permeability was assessed in MLVECs that were treated with control siRNA or siRNA targeting ZO-2, as described in the legend 
for Figure 7A. Data represent mean ± SD of 4 biological replicates. **P < 0.001, unpaired t test. (E) MLVECs were transfected with control siRNA or siRNA tar-
geting ZO-2. Two days later, primary mouse bone marrow–derived neutrophils (1 x 105 cells) were added to the inserts. Twenty-four hours later, trans migrated 
neutrophils were enumerated in the lower chamber. Data represent mean ± SD of 3 biological replicates. *P < 0.05, unpaired t test.
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a murine model of urinary tract infection (45). However, 
unlike the critical role that we established for monocytic 
production of IL-1β in pulmonary IRI, neutrophilic entry 
into bacterially infected urothelium was dependent on the 
production of TNF-α by monocytes, which induced the 
release of CXCL2 by macrophages, which in turn facilitat-
ed the secretion of MMP-9 by neutrophils.
We have recently shown that a population of lung-res-
ident nonclassical monocytes guides neutrophil recruit-
ment to pulmonary grafts after transplantation through 
production of the neutrophil chemoattractant CXCL2 (21). 
Our present study further demonstrates that graft-resi-
dent donor nonclassical monocytes mediate secretion of 
monocyte chemoattractants and play an important role in 
recruiting recipient spleen-derived classical monocytes to 
the graft. Importantly, reconstitution of NR4A1-deficient 
donor lungs with WT syngeneic nonclassical monocytes 
prior to transplantation restored the recruitment of classi-
cal monocytes following reperfusion. Hence, lung-resident 
nonclassical monocytes might provide the initial signals 
to recruit both classical monocytes and neutrophils from 
the periphery, whereas the recruited classical monocytes 
mediate the extravasation of the recruited neutrophils. We 
also show that classical monocytes that have been recruit-
ed to lung grafts express neutrophil chemokines and may 
therefore contribute to ongoing neutrophil recruitment and 
propagation of primary graft dysfunction.
The demonstration that splenic monocyte-derived 
IL-1β orchestrates critical steps of neutrophil entry into the 
tissue lays the ground for new therapeutic approaches for 
lung-transplant recipients and possibly patients suffering 
from other forms of acute lung injury. While the removal of 
the spleen is not practical in the clinical setting due to its invasive 
nature and increased risk for infectious complications, our find-
ings provide a platform for the development of strategies target-
ing classical monocytes and inhibiting IL-1β. While no agents that 
selectively deplete classical monocytes in humans are approved 
at the present time, several immunosuppressants that are in 
clinical use have been shown to affect monocyte function. For 
example, mTOR inhibitors can blunt the expression of chemok-
ines and mycophenolate mofetil can suppress IL-1β production 
in monocytes in vitro (46, 47). Furthermore, as human classical 
monocytes have been shown to express high levels of CCR2, 
oral CCR2 inhibitors that are in clinical trials for patients with 
metastatic pancreatic cancer may be efficacious in ameliorating 
primary graft dysfunction after lung transplantation (48). Sever-
al pharmacological approaches to block the activity of IL-1β are 
approved for use in the clinic. These include IL-1R antagonists, 
anti–IL-1β neutralizing antibodies, and soluble decoy receptors. 
Globally targeting IL-1β has been shown to be efficacious in ame-
liorating various inflammatory conditions in humans (49). Also, 
our recently described nanoclusters targeting CCR2 provide a 
platform to specifically blunt IL-1 production in classical mono-
cytes (22). Previous studies showing monocyte-dependent neu-
trophil entry in murine arthritis models raise the possibility that 
analogous mechanisms may regulate sterile inflammation in oth-
er organs and tissues (50).
proteins are regulated in various cell types. For example, although 
IFN-γ can disrupt tight junctional proteins in several endothelial 
and epithelial cells (42), it can enhance the function of the lung 
epithelial barrier (43).
We speculate that classical monocytes are activated in 
MyD88-dependent fashion once they enter the reperfused lung 
due to the release of endogenous substances from injured graft 
cells. Our laboratory has previously shown that neutrophilic 
entry into pulmonary graft tissue is impaired when the survival 
of alveolar macrophages is reduced (44). This defect could be 
reversed through administration of CXCL2 into the airways. It 
is possible that, in addition to downregulating tight junctional 
proteins, graft-infiltrating recipient classical monocytes induce 
the secretion of neutrophil chemokines by tissue-resident donor 
cells, such as alveolar macrophages. Collectively, our observa-
tions indicate that the production of inflammatory cytokines and 
chemokines by various cellular sources guides the recruitment 
of neutrophils into different compartments of the lung. Fur-
thermore, our work establishes a model whereby an interaction 
between various innate immune cells coordinates the recruit-
ment and extravasation of neutrophils, the cells that ultimately 
mediate tissue damage during reperfusion of transplanted lungs. 
This is reminiscent of a recent study that demonstrated that 
tissue-resident macrophages and inflammatory Ly6Chi mono-
cytes provide cues that guide neutrophils into infected tissue in 
Figure 9. Diagram depicting how spleen-derived classical monocytes mediate 
extravasation of neutrophils in reperfused lungs via MyD88/IL-1β–dependent 
pathway. Classical monocytes are released from the spleen after reperfusion of 
lungs. After recruitment to the lung, they produce IL-1β in MyD88-dependent fash-
ion. IL-1β signaling in endothelial cells results in the downregulation of ZO-2, which 
enhances endothelial permeability and facilitates neutrophil extravasation.
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were orotracheally intubated and connected to a rodent ventilator 
(Harvard Apparatus, model 845) with tidal volumes of 10 μl/g and 
respiratory rate set at 120 breaths per minute. Left dorsolateral tho-
racotomy was performed in the fourth intercostal space and a micro-
vascular clamp (Roboz) was applied across the left hilum, occluding 
the pulmonary artery, vein, and bronchus. While on single-lung ven-
tilation, the tidal volume was reduced to 6 μl/g and respiratory rate 
increased to 150 breaths per minute. The left hilum was occluded 
for a 60-minute period, at which point the microvascular clamp was 
removed. After recruitment of the left lung, the thoracotomy was 
closed and the mouse was removed from the ventilator and allowed 
to recover for the 2-hour reperfusion period. For some experiments, 
mice were splenectomized or underwent sham laparotomy immedi-
ately prior to hilar clamping.
Heterotopic spleen transplantation. The heterotopic spleen transplan-
tation procedure was adapted from a previously published technique 
(31). We used congenic CD45.1 donors and CD45.2 recipients to track 
donor- and recipient-derived immune cells. In brief, the donor spleen 
was harvested with an aortic cuff and the portal vein, ligating all arteri-
al and venous side branches off the splenic artery and vein. The spleen 
graft was then implanted in the recipient by anastomosing the donor aor-
tic cuff to the recipient abdominal aorta and the donor portal vein to the 
recipient inferior vena cava below the renal veins. The recipient under-
went a native splenectomy prior to implantation of the spleen graft.
Flow cytometry and cell sorting
Lung airways were lavaged 5 times with 0.5 ml PBS. BALF was cen-
trifuged, and the cell pellet was processed and prepared for flow 
cytometric analysis. After the lavage, lung tissue was digested and 
single cell suspensions were prepared as previously described (21, 27, 
29). Murine bone marrow was harvested from bilateral femurs and 
tibiae and passed through a 40 μm filter to achieve a single cell sus-
pension. Peripheral blood was prepared as previously described (37). 
Murine spleen was infiltrated with 2.5 ml of digestion buffer (2 mg/
ml collagenase D, 0.2 mg/ml DNase I, both from Roche, dissolved 
in HBSS with Ca2+ and Mn2+), followed by incubation in an orbital 
shaker at 37°C for 30 minutes, then pushed through a 40 μm filter 
to achieve a single cell suspension. Both bone marrow and spleen 
suspensions underwent red blood cell lysis using Pharm Lyse buffer 
(BD Biosciences). Live/dead staining was performed in protein-free 
solution (HBSS) using fixable viability dye eFluor 506 (eBioscience), 
followed by incubation with FcR-blocking reagent (Miltenyi Biotec). 
Cells were then stained using CD45 (clone 30-F11; BD Biosciences), 
CD45.2 (clone 104; Biolegend), CD45.1 (clone A20; Biolegend), Gr1 
(clone RB6-8C5; Biolegend), Ly6C (clone HK1.4; Thermo Fisher Sci-
entific), Ly6G (clone 1A8; Thermo Fisher Scientific), CD11b (clone 
M1/70; Thermo Fisher Scientific), CCR2 (clone FAB5538A; R&D 
System), CD24 (clone M1/69; Thermo Fisher Scientific), I-A/I-E 
(clone M5/114.15.2; BD Biosciences), CD3 (clone 145-2C11; BD Bio-
sciences), CD4 (clone RM4-5; BD Biosciences), CD8α (clone 53.6.7; 
Thermo Fisher Scientific), NK1.1 (clone PK136; Thermo Fisher Sci-
entific), CD64 (clone X54-5/7.1; Biolegend), CD115 (clone AFS98; 
Thermo Fisher Scientific), SiglecF (clone E50-2440; BD Bioscienc-
es), CD19 (clone 1D3; Biolegend), F4/80 (clone BM8; Thermo Fish-
er Scientific), CD11c (clone HL3; BD Biosciences), CD62L (clone 
MEL-14; BD Biosciences), CD117 (clone 2B8; Biolegend), and iso-
type control antibodies (BD Biosciences; BioLegend; and Thermo 
Methods
Mice and reagents
Male B6 (CD45.2+), B6.SJL-PtprcaPepcb/BoyJ (CD45.1+), B6;129S2- 
Nr4a1tm1Jmi/J (Nr4a1 KO), B6.129S7-Il1r1tm1Imx/J (IL-1R KO), B6.FVB-Tg(IT-
GAM-DTR/EGFP)34Lan/J (CD11b-DTR), BALB/c, and B6 Myd88-defi-
cient (MyD88 KO) mice were purchased from The Jackson Laboratory. 
B6 LysM–GFP (where LysM indicates lysozyme) mice were originally 
obtained from Klaus Ley (La Jolla Institute for Allergy and Immunology, 
La Jolla, California, USA), and B6 IL-1β–deficient (IL-1β KO) mice were 
obtained from Y. Iwakura (Tokyo University of Science, Chiba, Japan, 
USA) and bred in our facility (51). To deplete intravascular monocytes, 
mice were injected intravenously with 200 μl Clo-lip with PBS-liposomes 
as control 24 hours prior to lung IRI. Clo-lip and PBS- liposomes were 
purchased from Liposoma. Cytotoxic anti-CCR2 antibodies (a gift from 
Steffen Jung, Weizman Institute of Science, Israel) were used for selective 
depletion of CCR2+ classical monocytes as previously described (50 μg 
intravenously 24 hours prior to IRI) (21). DT (List Biologic Laboratories 
Inc.) was dissolved in 100 μl PBS and administered intraperitoneally to 
CD11b-DTR mice 24 hours prior to lung IRI. LPS O111:B4 (Sigma Aldrich) 
was dissolved in PBS and instilled intratracheally at a dose of 2 μg/g with 
PBS vehicle as control. For acid aspiration injury, 50 μl of hydrochloric 
acid (0.1N) was administered into the trachea.
Human samples
Lung graft samples were obtained at the conclusion of cold ischemic 
storage in Perfadex solution and approximately 120 minutes following 
reperfusion. A portion of the lung tissue was snap-frozen in liquid nitro-
gen and subsequently stored at –80°C until the time of processing for 
gene-expression analysis. A separate portion of lung tissue was fixed 
in 4% paraformaldehyde and subsequently processed for immunos-
taining. Myeloid cell populations were identified from fresh specimens 
using multicolor flow cytometry with our previously described protocols 
(21, 26, 27). For assessment of neutrophil extravasation, the percentage 
and absolute count of neutrophils were assessed in the BALF prior to 
lung harvest as well as 15 minutes following reperfusion. Human sam-
ples were randomly selected from a cohort of lung-transplant recipients 
who had consented to participate in these studies, in which graft tissue 
and BALF were collected before implantation and after reperfusion.
Surgical procedures
Murine lung transplantation. Orthotopic left lung transplants were per-
formed after 18 hours of cold ischemic storage as previously described 
(9, 44). Graft function was assessed by measuring arterial blood gases 
while delivering oxygen at an FiO2 of 100% after clamping the right 
pulmonary hilum for 4 minutes, as previously described (24). For 
some experiments, recipients were splenectomized or underwent a 
sham laparotomy immediately prior to lung transplantation (52). For 
adoptive transfer experiments, monocytes were isolated from spleens 
or bone marrow of B6 WT, B6 IL-1β–KO, or B6 MyD88-KO mice using 
a monocyte isolation kit purchased from Miltenyi Biotec. One hour 
prior to lung transplantation, 4 × 105 monocytes were injected via 
penile vein into recipients.
Lung hilar clamping. Mice were anesthetized by intraperitoneal 
injection of ketamine (100 mg/kg) (Henry Schein Animal Health) 
and xylazine (10 mg/kg) (RB). Buprenorphine (0.1 mg/kg) (Lloyd 
Laboratories) was given subcutaneously prior to skin incision. Mice 
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GAACTCAACT-3’ and 5’-ATCTTTTGGGGTCCGTCAACT-3’. Prim-
er sequences for human IL1B, TNFA, and RNA18S were as follows: 
IL1B: 5′-TTCGACACATGGGATAACGAGG-3′ and 5′-TTTTTGCT-
GTGAGTCCCGGAG-3′; TNFA: 5′-CCTGCCCCAATCCCTTTATT-3′ 
and 5′-CCCTAAGCCCCCAATTCTCT-3′; RNA18S: 5′-GGCCCTGTA-
ATTGGAATGAGTC-3′ and 5′-CCAAGATCCAACTACGAGCTT-3′.
Cell transfection
MLVECs were transfected with siRNA targeting ZO-2 (s232643; Thermo 
Fisher Scientific) or with control siRNA (AM4611: Thermo Fisher Scien-
tific) and cultured for 48 hours prior to analysis. Concentrations of siRNA 
and transfection reagent (Lipofectamine RNAiMAX; Thermo Fisher Sci-
entific) were selected per the manufacturer’s recommendations.
Endothelial permeability assays
MLVEC monolayer solute permeability was assessed using an in 
vitro vascular permeability 96-well assay kit (Trevigen). Primary 
MLVECs (1 × 105, passages 2–4 were used) were stimulated with var-
ious concentrations of IL-1β (R&D Systems; 401-ML) for 24 hours. 
Subsequently, monolayer solute permeability was determined by 
addition of high–molecular weight FITC-Dextran (Trevigen) to the 
Transwell insert. Twenty-four hours later, the fluorescence intensi-
ty in the media from the lower chamber was assessed using Bio-Rad 
CFX Connect Optical Module. In some experiments, endothelial cell 
monolayers were treated with IL-1R neutralization antibody (R&D 
Systems; AF771) or control goat IgG (R& D Systems; AB-108-C) for 
30 minutes prior to adding IL-1β. Fluorescence intensity was assessed 
in triplicate per experimental condition and normalized to untreated 
control cells. Primary mouse neutrophils were isolated from the bone 
marrow of WT B6 mice based on a negative selection as described 
previously (Miltenyi Biotec) (38). MLVECs (1 × 105) were seeded on a 
gelatin- coated Transwell membrane with a 3 μm pore size (Corning 
Life Science) and cultured for 24 hours. MLVECs were transfected 
with an siRNA targeting ZO-2 or with a control siRNA for 2 days as 
outlined above. Neutrophils (1 × 105) suspended in 100 μl medium 
were added to the Transwell insert after 2 washes with PBS and incu-
bated at 37°C for 24 hours. The number of transmigrated neutrophils 
was determined in the lower compartment.
Lung lysate preparation
Homogenized B6 WT lung samples (KINEMATICA Polytron PT 
1200) underwent 5 cycles of freeze-thawing in liquid nitrogen and a 
37°C water bath. This solution was filtered using a 70 μm strainer, and 
diluted supernatants were used to treat monocytes isolated from the 
bone marrow of B6 WT or MyD88-KO mice.
Western blotting
Lysates from endothelial cell cultures were prepared using RIPA buf-
fer containing protease inhibitors (P8340; Sigma-Aldrich) and a phos-
phatase inhibitor (P0044; Sigma-Aldrich) (55). Protein concentrations 
were quantitated using a bicinchoninic acid detection assay (Pierce). 
The lysates were resolved by SDS-PAGE, transferred to nitrocellulose 
membranes, and probed with antibodies against ZO-2 (Novus Biologi-
cals) and GAPDH (Novus Biologicals) (55, 56). The Western blot imag-
es were acquired by the ChemiDoc MP image system with Image Lab 
Software (version 5.1). The band intensities were quantitated by densi-
tometry using AlphaEase imaging software (version 4.0.1).
Fisher Scientific). To distinguish between intravascular and intersti-
tial neutrophils, phycoerythrin-labeled (PE-labeled) anti-Ly6G (1A8; 
eBioscience) was injected intravenously 5 minutes prior to sacrifice, 
and after digestion, cells were labeled with allophycocyanin-labeled 
(APC-labeled) anti-Ly6G (1A8; eBioscience), resulting in labeling 
of intravascular neutrophils as PE+APC+ and interstitial neutrophils 
as PE−APC+. In separate experiments, intravascular immune cells 
were stained with APC-labeled anti-CD45 (30-F11), while the whole 
tissue digest was stained with FITC-labeled anti-CD45. For some 
experiments examining gene expression, graft-infiltrating spleen 
and bone marrow CD90.2–NK1.1–B220–Ly6G–CD49b–CD11b+CD-
11cloI-AbloF4/80loLy6Chi monocytes were sorted after staining with 
antibodies specific for CD115 (c-fms AFS98; Thermo Fisher Scien-
tific), CD11b, Ly6C, CD45.1, and CD45.2 (Beckman Coulter Mo Flo). 
Antibodies used for human cell staining were CD45 (clone Hl30, 
eBioscience), CD14 (clone M5E2, eBioscience), HLA-DR (clone 
L243, eBioscience), CD169 (clone 7-239, BioLegend), CD15 (clone 
W6D3, BioLegend), CD11b (clone M1/70, BioLegend), CD16 (clone 
3G8, eBioscience), CD163 (clone GHI/61, eBioscience), and CD206 
(clone 19.2, eBioscience). Fixed samples were run on a custom LSR-
Fortessa Cell Analyzer (eBioscience). Flow cytometry data were ana-
lyzed with FlowJo v10 software.
PET/CT
PET/CT scanning using a CCR2-specific probe was performed as pre-
viously described (22, 53). Briefly, 2 hours after transplantation, 0- to 
60-minute dynamic PET/CT scanning was performed after the tail 
vein injection of 64Cu-radiolabeled DOTA-ECL1i conjugate (64Cu-DO-
TA-ECL1i, 3.7 MBq in 100 μl saline) using a cross-calibrated MicroPET 
Focus 220 (Siemens) or Inveon PET/CT system (Siemens). The tracer 
uptake was calculated as the percentage of injected dose per gram of 
tissue in the 3D regions of interest from PET images without partial 
volume correction using Inveon Research Workplace (Siemens) fol-
lowing this equation: SUV = radioactivity concentration in ROI (Bq/
ml)/(injected dose [Bq]/animal body weight [g]), where SUV = stan-
dardized uptake value, Bq = becquerel, and ROI = region of interest.
The quantitative tracer uptake in the ROI was normalized by the 
injected radioactivity and animal body weight.
Two-photon microscopy
Lung grafts were imaged by intravital 2-photon microscopy 2 hours 
after reperfusion for a time period of 2 hours as previously described 
(44, 54). Qdot 655 (30 μl) (Life Technologies) was injected to label ves-
sels. Grafts were exposed and imaged with a custom 2-photon micro-
scope using ImageWarp (A&B Software). Sequential z-sections (2.5 
μm each) were acquired, yielding an imaging volume of 220 × 247.5 
× 50 μm3. Analyses were performed with Imaris (Bitplane). For each 
mouse, up to 5 lung areas at least 80 μm deep were analyzed (44, 54).
Quantitative PCR
Homogenized lung graft tissue, cultured primary MLVECs (Cell Bio-
logics), and sorted monocytes were lysed with TRIzol (Thermo Fisher 
Scientific) as previously described (55). Total RNA was isolated using 
QIAGEN RNeasy Mini Kit (QIAGEN), and quantitative PCR was per-
formed as previously described (55, 56). Primer sequences for mouse 
Tnfa, Cxcl1, Cxcl2, Cxcl5, and Rn18s were previously described (44, 
57). Primer sequences for mouse Il1b were 5’-GCAACTGTTCCT-
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Immunostaining
Frozen lung tissues were prepared and sectioned as previously described 
(54). MLVECs were fixed with 4% paraformaldehyde for 15 minutes. 
Cells were then permeabilized (0.1% Triton X-100 in PBS for 30 minutes 
on ice) and blocked. Tissue sections and cells were stained with antibod-
ies against ZO-2, CD31 (clone P2B1; Abcam), Alexa Fluor 647–conjugat-
ed CD14 (clone M5E2; Novus Biologicals), CD15 (clone MY-1; Abcam), 
and PE-conjugated CD16 (clone 3G8; BioLegend). ZO-2 was detected 
using an Alexa Fluor 555–conjugated secondary antibody, and both 
CD31 and CD15 were detected using an Alexa Fluor 488–conjugated 
secondary antibody (Thermo Fisher Scientific). Nuclei were stained with 
ProLong Gold Antifade Mountant with DAPI (Thermo Fisher Scientific). 
Images were acquired with a Zeiss LMS 510 Confocal Laser Scanning 
Microscope or Zeiss Observer Fluorescent Microscope using a ×40 water 
immersion lens (Zeiss). For both murine and human tissue, intensities 
of ZO-2 and DAPI staining were quantitated using Zeiss Efficient Nav-
igation software (ZEN; Zeiss). Relative mean fluorescence intensity of 
ZO-2 and DAPI were analyzed. The intensity of ZO-2 was normalized 
to that of DAPI. For some experiments, numbers of classical monocytes 
(CD14+CD16dim), nonclassical monocytes (CD14+CD16+), and neutro-
phils (CD15+CD16+) were enumerated at ×40 magnification. For all 
experiments, 5 fields per tissue section were randomly chosen, digitally 
captured, and analyzed in blinded fashion.
Statistics
Data were analyzed by Prism version 7.0d. For the comparison of 2 
groups, data were analyzed with the Mann-Whitney U test or, when indi-
cated, with 2-tailed paired or unpaired t test or the Pearson’s correlation 
coefficient test, as described for individual experiments. For multiple 
group comparisons, we tested for normality (Shapiro-Wilks test) and 
data were analyzed by 1-way ANOVA with post hoc Holm-Šídák test. A 
P value of less than 0.05 was considered significant. Statistical outliers 
were determined using the GraphPad outlier calculator using α = 0.05.
Study approval
All procedures were approved by the Institutional Animal Studies Com-
mittees at Washington University and Northwestern University. Animals 
received humane care in compliance with the NIH Guide for the Care 
and Use of Laboratory Animals (National Academies Press, 2011) and the 
Principles of Laboratory Animal Care formulated by the National Society 
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